Asia Pacific Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Sciatica Treatment Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).

The growing popularity of sciatica treatments in the automobile sector, rising consumer desire for more fuel-efficient engines, increasing use of electric cars, and other factors are all contributing to the potential development of the sciatica treatment market during the anticipated period. Researchers involved in creating a new intervention are a driving force behind the acceleration of market expansion. The intense desire for disease-specific innovative treatments further boosts the total market demand for this category. The development of medications used to treat sciatica-related problems is another driving force.

Also, the population has access to various indoor professions because of expanding industry. Because of the increasing burden, the working population spends much time sitting down. Long periods of sitting may cause sciatica to develop or become worse. As a result, the increasing number of people in the workforce may encourage the spread of sciatica treatments. Moreover, sacral and lumbar spinal tumors may cause leg paralysis and sciatic back discomfort. Thus, throughout the scheduled time, the increased incidence of cancer among the population may provide new chances for the sciatica treatment market.

One of the world's fastest-growing aging populations is in China. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. The creation of age-friendly towns and communities where older people may flourish and continue to make significant contributions to society is essential due to the increasingly aging population. In addition, there is an increase in demand for sciatica therapy in the APAC area due to the region's aging population and growing osteoarthritis prevalence.

The China market dominated the Asia Pacific Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $62,929.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 3.6% during (2022 - 2028). Additionally, The India market would display a CAGR of 4.9% during (2022 - 2028).

Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Sciatica Treatment Market is Projected to reach USD 810.4 Million by 2028, at a CAGR of 3.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)

Scope of the Study

Market Segments Covered in the Report:

By Type

• Chronic
• Acute
• Others

By Distribution Channel

• Retail & Specialty Pharmacies
• Hospital Pharmacies
• Online Providers

By Drug Class

• Non-Steroidal anti-inflammatory
• Steroids
• Antidepressants
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Sorrento Therapeutics, Inc.
• Alkem Laboratories Ltd.
• Amneal Pharmaceuticals, Inc.
• Aurobindo Pharma Limited
• Novartis AG
• Cadila Healthcare Ltd. (Zydus Cadila)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Sciatica Treatment Market, by Type
1.4.2 Asia Pacific Sciatica Treatment Market, by Distribution Channel
1.4.3 Asia Pacific Sciatica Treatment Market, by Drug Class
1.4.4 Asia Pacific Sciatica Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Sciatica Treatment Market by Type
3.1 Asia Pacific Chronic Market by Country
3.2 Asia Pacific Acute Market by Country
3.3 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Sciatica Treatment Market by Distribution Channel
4.1 Asia Pacific Retail & Specialty Pharmacies Market by Country
4.2 Asia Pacific Hospital Pharmacies Market by Country
4.3 Asia Pacific Online Providers Market by Country

Chapter 5. Asia Pacific Sciatica Treatment Market by Drug Class
5.1 Asia Pacific Non-Steroidal anti-inflammatory Market by Country
5.2 Asia Pacific Steroids Market by Country
5.3 Asia Pacific Antidepressants Market by Country
5.4 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Sciatica Treatment Market by Country
6.1 China Sciatica Treatment Market
6.1.1 China Sciatica Treatment Market by Type
6.1.2 China Sciatica Treatment Market by Distribution Channel
6.1.3 China Sciatica Treatment Market by Drug Class
6.2 Japan Sciatica Treatment Market
6.2.1 Japan Sciatica Treatment Market by Type
6.2.2 Japan Sciatica Treatment Market by Distribution Channel
6.2.3 Japan Sciatica Treatment Market by Drug Class
6.3 India Sciatica Treatment Market
6.3.1 India Sciatica Treatment Market by Type
6.3.2 India Sciatica Treatment Market by Distribution Channel
6.3.3 India Sciatica Treatment Market by Drug Class
6.4 South Korea Sciatica Treatment Market
6.4.1 South Korea Sciatica Treatment Market by Type
6.4.2 South Korea Sciatica Treatment Market by Distribution Channel
6.4.3 South Korea Sciatica Treatment Market by Drug Class
6.5 Singapore Sciatica Treatment Market
6.5.1 Singapore Sciatica Treatment Market by Type
6.5.2 Singapore Sciatica Treatment Market by Distribution Channel
6.5.3 Singapore Sciatica Treatment Market by Drug Class
6.6 Malaysia Sciatica Treatment Market
6.6.1 Malaysia Sciatica Treatment Market by Type
6.6.2 Malaysia Sciatica Treatment Market by Distribution Channel
6.6.3 Malaysia Sciatica Treatment Market by Drug Class
6.7 Rest of Asia Pacific Sciatica Treatment Market
6.7.1 Rest of Asia Pacific Sciatica Treatment Market by Type
6.7.2 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel
6.7.3 Rest of Asia Pacific Sciatica Treatment Market by Drug Class

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Johnson & Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Sorrento Therapeutics, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expenses
7.6 Alkem Laboratories Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Amneal Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental
7.7.4 Research & Development Expenses
7.8 Aurobindo Pharma Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Novartis AG
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Cadila Healthcare Ltd. (Zydus Cadila)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense

TABLE 1 Asia Pacific Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 2 Asia Pacific Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 3 Asia Pacific Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 4 Asia Pacific Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 5 Asia Pacific Chronic Market by Country, 2018 - 2021, USD Thousands
TABLE 6 Asia Pacific Chronic Market by Country, 2022 - 2028, USD Thousands
TABLE 7 Asia Pacific Acute Market by Country, 2018 - 2021, USD Thousands
TABLE 8 Asia Pacific Acute Market by Country, 2022 - 2028, USD Thousands
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 11 Asia Pacific Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 12 Asia Pacific Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 13 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Thousands
TABLE 14 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Thousands
TABLE 15 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Thousands
TABLE 16 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Thousands
TABLE 17 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Thousands
TABLE 18 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Thousands
TABLE 19 Asia Pacific Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 20 Asia Pacific Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 21 Asia Pacific Non-Steroidal anti-inflammatory Market by Country, 2018 - 2021, USD Thousands
TABLE 22 Asia Pacific Non-Steroidal anti-inflammatory Market by Country, 2022 - 2028, USD Thousands
TABLE 23 Asia Pacific Steroids Market by Country, 2018 - 2021, USD Thousands
TABLE 24 Asia Pacific Steroids Market by Country, 2022 - 2028, USD Thousands
TABLE 25 Asia Pacific Antidepressants Market by Country, 2018 - 2021, USD Thousands
TABLE 26 Asia Pacific Antidepressants Market by Country, 2022 - 2028, USD Thousands
TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 29 Asia Pacific Sciatica Treatment Market by Country, 2018 - 2021, USD Thousands
TABLE 30 Asia Pacific Sciatica Treatment Market by Country, 2022 - 2028, USD Thousands
TABLE 31 China Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 32 China Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 33 China Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 34 China Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 35 China Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 36 China Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 37 China Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 38 China Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 39 Japan Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 40 Japan Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 41 Japan Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Japan Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Japan Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 44 Japan Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 45 Japan Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 46 Japan Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 47 India Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 48 India Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 49 India Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 50 India Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 51 India Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 52 India Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 53 India Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 54 India Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 55 South Korea Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 56 South Korea Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 57 South Korea Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 58 South Korea Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 59 South Korea Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 60 South Korea Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 61 South Korea Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 62 South Korea Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 63 Singapore Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 64 Singapore Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 65 Singapore Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 66 Singapore Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 67 Singapore Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 68 Singapore Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 69 Singapore Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 70 Singapore Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 71 Malaysia Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 72 Malaysia Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 73 Malaysia Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 74 Malaysia Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 75 Malaysia Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 76 Malaysia Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 77 Malaysia Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 78 Malaysia Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 79 Rest of Asia Pacific Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 80 Rest of Asia Pacific Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 81 Rest of Asia Pacific Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 82 Rest of Asia Pacific Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 83 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 84 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 85 Rest of Asia Pacific Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 86 Rest of Asia Pacific Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 87 Key Information – Abbott Laboratories
TABLE 88 Key information –Johnson & Johnson
TABLE 89 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 90 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 91 Key Information – Sorrento Therapeutics, Inc.
TABLE 92 Key Information – Alkem Laboratories Ltd.
TABLE 93 Key Information – Amneal Pharmaceuticals, Inc.
TABLE 94 key information – Aurobindo Pharma Limited
TABLE 95 Key Information – Novartis AG
TABLE 96 Key Information – Cadila Healthcare Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories